| PHC421H1 | Biomolecular Interactions and Thermodynamics I | 2 | 100% | 60% | 80% |
| PHC331H1 | Establishing the Bioequivalence of Pharmaceutical Products | 1 | 100% | 60% | 100% |
| PHC230H1 | Pharmaceutics 1 | — | — | — | — |
| PHC300H1 | Molecular Pharmacology 1 | — | — | — | — |
| PHC301H1 | Molecular Pharmacology 2 | — | — | — | — |
| PHC320H1 | Chemistry and Technologies in Drug Discovery | — | — | — | — |
| PHC330H1 | Pharmaceutics 2 | — | — | — | — |
| PHC340Y1 | Pharmaceutical Chemistry Laboratory | — | — | — | — |
| PHC401H1 | Drug Transport across Biological Membranes | — | — | — | — |
| PHC420H1 | Application of Medicinal Chemistry to Pharmacology | — | — | — | — |
| PHC430H1 | Recent Developments in Dosage Form Design | — | — | — | — |
| PHC431H1 | Latest Developments in Drug Discovery | — | — | — | — |
| PHC432H1 | Nanomedicines in Oncology | — | — | — | — |
| PHC435H1 | Pharmaceutical Data Acquisition and Analysis | — | — | — | — |
| PHC460H1 | Fundamentals of Drug Discovery | — | — | — | — |
| PHC462H1 | Clinical Drug Development | — | — | — | — |
| PHC470H1 | Global Pharmaceutical Policy | — | — | — | — |
| PHC489Y1 | Pharmaceutical Chemistry Research | — | — | — | — |